Trademark: 90827345
Word
KENLIVABY
Status Date
Tuesday, September 3, 2024
Filing Date
Wednesday, July 14, 2021
Published for Opposition
Tuesday, July 19, 2022
5 Pharmaceutical preparations for human use for the treatment of Fabry disease and symptoms and sequelae of Fabry disease, and for the treatment of glycolipid storage disorders
Apr 4, 2022
Assigned To Examiner
Jul 17, 2021
New Application Entered
Sep 17, 2021
New Application Office Supplied Data Entered
Apr 11, 2022
Notification Of Non-Final Action E-Mailed
Apr 11, 2022
Non-Final Action Written
Apr 11, 2022
Non-Final Action E-Mailed
Jun 15, 2022
Examiner's Amendment Entered
Jun 15, 2022
Examiners Amendment -Written
Jun 15, 2022
Examiners Amendment E-Mailed
Jun 15, 2022
Notification Of Examiners Amendment E-Mailed
Jun 15, 2022
Approved For Pub - Principal Register
Jul 19, 2022
Published For Opposition
Jun 29, 2022
Notification Of Notice Of Publication E-Mailed
Jul 19, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 13, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 28, 2023
Sou Teas Extension Received
Mar 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 21, 2023
Sou Extension 2 Filed
Aug 21, 2023
Sou Extension 2 Granted
Feb 29, 2024
Sou Extension 3 Granted
Feb 28, 2023
Sou Extension 1 Filed
Feb 28, 2023
Sou Extension 1 Granted
Aug 21, 2023
Sou Teas Extension Received
Aug 23, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 29, 2024
Sou Extension 3 Filed
Mar 1, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 29, 2024
Sou Teas Extension Received
Sep 3, 2024
Sou Teas Extension Received
Sep 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Sep 3, 2024
Sou Extension 4 Filed
Sep 3, 2024
Sou Extension 4 Granted
Trademark Alertz updated from USPTO on 2030-01-24
